Nikita A Mitkin

Dr. Nikita A Mitkin

Lacrocore Inc., Newton, Massachusetts, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NMNikita A Mitkin
Nikita A Mitkin
CHChristina D Hook
Christina D Hook
ASAnton M Schwartz
Anton M Schwartz
SBSubir Biswas
Subir Biswas
DKDmitry V Kochetkov
Dmitry V Kochetkov
DKDmitry Kuprash
Dmitry Kuprash
Elevated expression of chemokine receptors in tumors has been reported in many instances and is related to a number of survival advantages for tumor cells including abnormal activation of prosurvival intracellular pathways. In this work we demonstrated an inverse correlation between expression levels of p53 tumor suppressor and CXCR5 chemokine receptor in MCF-7 human breast cancer cell line. Lentiviral transduction of MCF-7 cells with p53 shRNA led to elevated CXCR5 at both mRNA and protein levels. Functional activity of CXCR5 in p53-knockdown MCF-7 cells was also increased as shown by activation of target gene expression and chemotaxis in response to B-lymphocyte chemoattractant CXCL13. Using deletion analysis and site-directed mutagenesis of the cxcr5 gene promoter and enhancer elements, we demonstrated that p53 appears to act upon cxcr5 promoter indirectly, by repressing the activity of NFκB transcription factors. Using chromatin immunoprecipitation and reporter gene analysis, we further demonstrated that p65/RelA was able to bind the cxcr5 promoter in p53-dependent manner and to directly transactivate it when overexpressed. Through the described mechanism, elevated CXCR5 expression may contribute to abnormal cell survival and migration in breast tumors that lack functional p53.

6 August 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
VVVladimir Veselovsky
Vladimir Veselovsky
MRMikhail Romanov
Mikhail Romanov
PZPolina Zoruk
Polina Zoruk
ALAndrey Larin
Andrey Larin
VBVladislav Babenko
Vladislav Babenko
KKKsenia Klimina
Ksenia Klimina
Soil microbiome profiling is crucial for understanding microbial diversity and its roles in ecosystem functioning and agricultural productivity. Recent advancements in high-throughput sequencing, particularly Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT), offer long-read sequencing capabilities that enhance microbial community analysis. In this study, we performed a comparative evaluation of 16S rRNA gene sequencing using Illumina (V4 and V3–V4 regions), PacBio (full-length and trimmed V3–V4/V4 regions), and ONT (full-length) to assess bacterial diversity in soil microbiomes. We analyzed three distinct soil types and applied standardized bioinformatics pipelines tailored to each platform. To ensure comparability, sequencing depth was normalized across platforms (10,000, 20,000, 25,000, and 35,000 reads per sample). Our results demonstrated that ONT and PacBio provided comparable bacterial diversity assessments, with PacBio showing slightly higher efficiency in detecting low-abundance taxa. Despite differences in sequencing accuracy, ONT produced results that closely matched those of PacBio, suggesting that ONT’s inherent sequencing errors do not significantly affect the interpretation of well-represented taxa. Our study demonstrated that, regardless of the sequencing technology used and the choice of the target region (full-length 16S rRNA gene or its regions), microbial community analysis ensures clear clustering of samples based on soil type. The only exception is the V4 region, where no soil-type clustering is observed (p = 0.79). These results provide a comprehensive evaluation of sequencing platform performance.

8 July 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AGAlisa M. Gorbacheva
Alisa M. Gorbacheva
AUAksinya N. Uvarova
Aksinya N. Uvarova
AUAlina S. Ustiugova
Alina S. Ustiugova
ABArindam Bhattacharyya
Arindam Bhattacharyya
KKKirill V. Korneev
Kirill V. Korneev
NMNikita A Mitkin
Nikita A Mitkin
Transforming growth factor beta (TGF-β) is the main cytokine responsible for the induction of the epithelial-mesenchymal transition of breast cancer cells, which is a hallmark of tumor transformation to the metastatic phenotype. Recently, research demonstrated that the chemokine CCL2 gene expression level directly correlates with the TGF-β activity in breast cancer patients. CCL2 attracts tumor-associated macrophages and is, therefore, considered as an important inductor of breast cancer progression; however, the precise mechanisms underlying its regulation by TGF-β are unknown. Here, we studied the behavior of the CCL2 gene in MDA-MB-231 and HCC1937 breast cancer cells representing mesenchymal-like phenotype activated by TGF-β. Using bioinformatics, deletion screening and point mutagenesis, we identified binding sites in the CCL2 promoter and candidate transcription factors responsible for its regulation by TGF-β. Among these factors, only the knock-down of EGR1 and RXRA made CCL2 promoter activity independent of TGF-β. These factors also demonstrated binding to the CCL2 promoter in a TGF-β-dependent manner in a chromatin immunoprecipitation assay, and point mutations in the EGR1 and RXRA binding sites totally abolished the effect of TGF-β. Our results highlight the key role of EGR1 and RXRA transcription factors in the regulation of CCL2 gene in response to TGF-β pathway.

27 February 2018 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
Kirill V. KorneevKirill V. Korneev
Kirill V. Korneev
AKAnna N. Kondakova
Anna N. Kondakova
ESEkaterina N. Sviriaeva
Ekaterina N. Sviriaeva
NMNikita A Mitkin
Nikita A Mitkin
APAngelo Palmigiano
Angelo Palmigiano
DKDmitry Kuprash
Dmitry Kuprash
Toll-like receptor 4 (TLR4) initiates immune response against Gram-negative bacteria upon specific recognition of lipid A moiety of lipopolysaccharide (LPS), the major component of their cell wall. Some natural differences between LPS variants in their ability to interact with TLR4 may lead to either insufficient activation that may not prevent bacterial growth, or excessive activation which may lead to septic shock. In this study we evaluated the biological activity of LPS isolated from pathogenic strain of Campylobacter jejuni, the most widespread bacterial cause of foodborne diarrhea in humans. With the help of hydrophobic chromatography and MALDI-TOF mass spectrometry we showed that LPS from a C. jejuni strain O2A consists of both hexaacyl and tetraacyl forms. Since such hypoacylation can result in a reduced immune response in humans, we assessed the activity of LPS from C. jejuni in mouse macrophages by measuring its capacity to activate TLR4-mediated proinflammatory cytokine and chemokine production, as well as NFκB-dependent reporter gene transcription. Our data support the hypothesis that LPS acylation correlates with its bioactivity.

1 March 2020 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
Kirill V. KorneevKirill V. Korneev
Kirill V. Korneev
ESEkaterina N. Sviriaeva
Ekaterina N. Sviriaeva
NMNikita A Mitkin
Nikita A Mitkin
AGAlisa M. Gorbacheva
Alisa M. Gorbacheva
AUAksinya N. Uvarova
Aksinya N. Uvarova
DKDmitry Kuprash
Dmitry Kuprash

28 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AZAnastasia Zotova
Anastasia Zotova
APAlexey Pichugin
Alexey Pichugin
AAAnastasia Atemasova
Anastasia Atemasova
EKEkaterina Knyazhanskaya
Ekaterina Knyazhanskaya
ELElena Lopatukhina
Elena Lopatukhina
DMDmitriy Mazurov
Dmitriy Mazurov
We describe Surface Oligopeptide knock-in for Rapid Target Selection (SORTS), a novel method to select mammalian cells with precise genome modifications that does not rely on cell cloning. SORTS is designed to disrupt the target gene with an expression cassette encoding an epitope tag embedded into human glycophosphatidylinositol (GPI)-anchored protein CD52. The cassette is very short, usually less than 250 nucleotides, which simplifies donor DNA construction and facilitates transgene integration into the target locus. The chimeric protein is then expressed from the target promoter, processed and exposed on the plasma membrane where it serves as a marker for FACS sorting with tag-specific antibodies. Simultaneous use of two different epitope tags enables rapid isolation of cells with biallelic knock-ins. SORTS can be easily and reliably applied to a number of genome-editing problems such as knocking out genes encoding intracellular or secreted proteins, protein tagging and inactivation of HIV-1 provirus.